Hematology analyzers for human and veterinary diagnostics
Boule is a global diagnostics company specialized on decentralized blood diagnostics. Our history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell counter. This is an early predecessor of today’s instruments from Boule. The founders of Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., (CDS) has a similar history from Coulter Corporation which developed the world’s first blood cell counter.
Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets.
Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.
Boule develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents, controls and calibrators for both human and veterinary diagnostic markets. Boule´s automated hematology analyzers have e. g. been used by clinical laboratories in general health screenings across the globe for more than 60 years. Our blood tests help provide one of the first and most important indicators of a disease state.